Daniel Barber is not just leading Aquestive Therapeutics; he is financially invested in its success too. Between 2019 and 2020, he engaged in various insider trading activities that collectively amounted to over $4 million, showcasing his commitment to the company....
Daniel Barber is not just leading Aquestive Therapeutics; he is financially invested in its success too. Between 2019 and 2020, he engaged in various insider trading activities that collectively amounted to over $4 million, showcasing his commitment to the company. His biggest trades were made during 2020, with an impressive transaction of nearly $1 million in August alone. This active process of buying and selling stock shares indicates his confidence in the company’s future. Following his move to CEO in 2022, he received performance stock units that could significantly boost his holdings if the company's stock price hits certain targets. As of 2023, his holdings reflect a deep financial tie to the company's performance, pointing to his role not just as a leader but as a stakeholder in its achievements.